Roche Receives CE Mark for Blood-Based Immunoassay Test to Detect Alzheimer’s Genetic Risk Factor ApoE4
Roche has received CE Mark approval for its Elecsys Apolipoprotein E4 (ApoE4) biomarker test, an in-vitro diagnostic (IVD)…
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer’s disease
The Elecsys ApoE4 test is the first CE marked in-vitro diagnostic immunoassay to identify individuals carrying the ApoE4…
Roche secures CE mark for blood test to identify ApoE4 carriers
Roche Holding AG received CE Mark approval for its Elecsys Apolipoprotein E4 (ApoE4) biomarker test, an in vitro…
Roche Advances in Alzheimer’s Diagnostics with New Blood Test Approval
Roche, Advances
17.03.2026 – 05:26:16 | boerse-global.de
Roche gains CE mark for a blood…